‘Pseudo-Pharmas’ Are Getting Bigger ... and Getting Creative When It Comes to Pricing

And a whole passel of links on everything from Trump math to the decline of Part D plans to a first-person account of prior auth madness

Brian Reid

Jul 23, 2025